mCRPC-യ്ക്കുള്ള ചികിത്സയുടെ സാധ്യതകളും പുരോഗതിയും

(2:39)

എംസിആർപിസിക്കുള്ള ഒപ്റ്റിമൽ ചികിത്സാ സമീപനങ്ങൾ

(3:55)

mCRPC-യുടെ പരിചരണ നിലവാരം

(3:18)

Point-Counterpoint: Management of mCRPC

(20:48)

Role of Chemotherapy, Treatment Sequencing in mCRPC and Future Directions

(20:26)

Molecular and clinical characterization of mCRPC patients achieving deep PSA responses to BAT

(4:54)

PARPi in mCRPC

(10:25)

UROwebinar: New treatment options in mCRPC

(1:4:24)

The Differences Between mCRPC and nmCRPC

(2:50)

Dr. Sehdev, Medical Oncologist: What is mCRPC and what is the prognosis?

(1:5)

Overall Survival Data in mCRPC

(2:49)

Ep. 10: How Has the mCRPC Treatment Landscape Changed?

(8:21)

Metastatic Castration Resistant Prostate Cancer (mCRPC) – Inroads in Improved Outcomes

(16:39)

Monitoring Response of metastatic castration resistance prostate cancer (mCRPC)

(18:8)

mCRPC How do we treat today and what is the perspective for the future.

(26:19)

Treatment Approaches for Newly Diagnosed mCRPC

(11:)

Improving the Prognosis for Patients With mCRPC

(4:56)

Dr Neeraj Agarwal on mCRPC trials in prostate cancer

(1:35)

Impressions of a Patient With Progression to mCRPC

(3:51)

Case 3: Treatment After Progression to mCRPC

(7:52)

Cabazitaxel safe and effective in mCRPC

(3:47)

First-line treatments for patients with mHSPC and mCRPC

(2:34)

Biologic Understandings of Bone Metastasis in mCRPC

(5:55)